CHICAGO, Nov. 25, 2020 /PRNewswire/ — The Basis for Sarcoidosis Analysis (FSR), the main worldwide group devoted to advancing analysis and enhancing care for people dwelling with sarcoidosis, proclaims the appointment of Elliott Crouser, MD as Chair of the group’s Scientific Advisory Board (SAB).
“Dr. Crouser is exceptionally well-respected and a frontrunner within the sarcoidosis analysis and remedy subject,” Chair of FSR Board of Administrators, Louise Perkins, mentioned. “We’re thrilled that he’ll lead our Scientific Advisory Board, an esteemed group of devoted researchers, scientists and physicians on the forefront of combating towards sarcoidosis.”
Dr. Crouser has over 31 years of medical expertise and has been a member of FSR’s SAB since 2016. He’s a professor of medication at Ohio State College the place he makes a speciality of Pulmonary and Vital Care Drugs with a give attention to translational analysis on systemic inflammatory ailments involving the lungs. In 25 years of supported analysis, Dr. Crouser’s laboratory has contributed to the publication of greater than 100 peer-reviewed manuscripts, together with the primary efforts to review sarcoidosis illness mechanisms by deeply scrutinizing genetic information (2009) and the primary scientific follow tips for sarcoidosis which have been endorsed by the American Thoracic Society in 2020.
Along with his analysis, Dr. Crouser served because the President of the American Affiliation of Sarcoidosis and Different Granulomatous Problems (AASOG) from 2017-2019 and has advocated for the sarcoidosis group by way of engagement with the Nationwide Institutes of Well being.
“As Chair of FSR’s SAB, I sit up for working with my colleagues who share my dedication to advancing analysis and enhancing well being outcomes for sarcoidosis sufferers. We try to raise the precedence for sarcoidosis analysis to advertise sustainable funding and foster mentorship alternatives for partaking proficient younger investigators to deal with the various unmet wants of sarcoidosis sufferers, together with offering extra personalised, disease-specific therapies.”
The Basis for Sarcoidosis Analysis maintains a world Scientific Advisory Board composed of 20 world-renowned key opinion leaders throughout the fields of sarcoidosis, medical analysis, remedy improvement, and medical follow. “We’re honored to have Dr. Crouser on the helm of FSR’s SAB. The SAB is integral in offering important perception, scientific path, and experience to the Basis as we work in the direction of higher affected person outcomes, extra well timed analysis, improved remedy choices and offering alternatives for affected person help and care,” mentioned FSR’s CEO, Mary McGowan. For an entire itemizing of FSR’s SAB members please go to stopsarcoidosis.org/SAB.
Sarcoidosis is a uncommon inflammatory illness that causes cells to type clumps known as granulomas. When too many granulomas type on an organ, they’ll intervene with the organ’s perform. Sarcoidosis can have an effect on any organ within the physique; nevertheless, 90 p.c of circumstances affect the lungs.
Concerning the Basis for Sarcoidosis Analysis
The Basis for Sarcoidosis Analysis is the main worldwide group devoted to discovering a treatment for sarcoidosis and to enhancing look after sarcoidosis sufferers. Since its institution in 2000, FSR has fostered over $5 million in sarcoidosis-specific analysis efforts. For extra details about FSR go to: stopsarcoidosis.org
CONTACT: Maggie Hudson, [email protected]
SOURCE Basis for Sarcoidosis Analysis